Stock ZS PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

ZS Pharma Inc Stock

Equities

US98979G1058

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for ZS Pharma Inc
2016 AstraZeneca : potassium drug delayed by manufacturing snag RE
2015 AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug RE

Latest news about ZS Pharma Inc

AstraZeneca : potassium drug delayed by manufacturing snag RE
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug RE
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug RE
AbbVie : AstraZeneca chases Acerta to secure next cancer drug winner RE
AstraZeneca : in talks to buy cancer drugmaker Acerta for $5 billion: WSJ RE
Wall St. flat as rate hike eyed; banks counter utilities drop RE
Actelion : AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion RE
Actelion : raises 2015 earnings forecast after strong drug sales RE
More news

Press releases ZS Pharma Inc

ZS Pharma : AstraZeneca completes acquisition of ZS Pharma PU
ZS Pharma Announces New Employment Inducement Grants GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Shareholders To Contact The Firm For Additional Information BU
ZS PHARMA : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with AstraZeneca PLC BU
ZS Pharma Announces New Employment Inducement Grants GL
More press releases

News in other languages on ZS Pharma Inc

AstraZeneca : confirme des discussions avec Acerta Pharma
AstraZeneca : discuterait du rachat d'Acerta Pharma
Alibaba : Wall Street finit peu changée, la hausse des taux se précise
Wall Street finit peu changée, la hausse des taux se précise
Alibaba : Wall Street ouvre hésitante après les chiffres de l'emploi
More news

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock